Pfizer (PFE) says antiviral for covid significantly reduced risk of hospitalization or death

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/13/2026

1. MIRM
2. META
3. JNJ
4. SPY
5. HUM
6. MSFT
7. DMART:IN
8. NVDA
9. PLTR
10. MRK

Go back to Pfizer (PFE) says antiviral for covid significantly reduced risk of hospitalization or death

Pfizer Announces Additional Phase 2/3 Study Results Confirming Robust Efficacy of Novel COVID-19 Oral Antiviral Treatment Candidate in Reducing Risk of Hospitalization or Death

December 14, 2021 6:45 AM EST

Final data available from all high-risk patients enrolled in EPIC-HR study (n= 2,246) confirmed prior results of interim analysis showing PAXLOVID (nirmatrelvir [PF-07321332] tablets and ritonavir tablets) reduced risk of hospitalization or death by 89% (within three days of symptom onset) and 88% (within five days of symptom onset) compared to placebo; no deaths compared to placebo in non-hospitalized, high-risk adults with COVID-19 The above data have been shared with the U.S. Food and Drug Administration (FDA) as part of an ongoing rolling submission for Emergency Use Authorization (EUA) Separately, interim analyses of an... More